| I-02 Mike Dunlavey A new language for complex ODE models Wednesday 10:20-11:40 |
| I-12 Jonathan French A case study in comparing cognitive development across populations Wednesday 10:20-11:40 |
| I-47 Stephen Duffull The influence of parameterisation on local identifiability Wednesday 10:20-11:40 |
| I-67 Anne Kuemmel PECAN, a Shiny application for calculating confidence and prediction intervals for pharmacokinetic and pharmacodynamic models Wednesday 10:20-11:40 |
| II-28 Elisa Borella Development and integration of the WinBUGS connector in the DDMoRe Interoperability Framework Wednesday 15:10-16:30 |
| II-33 Vincent Buchheit Added value of the Data Scientist role in a Clinical Pharmacometric group Wednesday 15:10-16:30 |
| II-41 Aziz Chaouch Building up a posteriori percentiles for Therapeutic Drug Concentration Monitoring Wednesday 15:10-16:30 |
| II-42 Jonathan Chard Pharmacometrics workflow: standards for provenance capture and workflow definition Wednesday 15:10-16:30 |
| III-27 Michael Morimoto A quantitative physiologic model of the interaction of nutrition and infection in determining the energy available for growth Thursday 10:05-11:30 |
| III-32 C.J. Musante The International Society of Pharmacometrics’ Special Interest Group on Quantitative Systems Pharmacology: Developing a community and advancing a field Thursday 10:05-11:30 |
| III-51 Séverine Petitprez Population pharmacokinetic meta-analysis of seven antiretroviral drugs Thursday 10:05-11:30 |
| III-57 Teun Post Application of a Shiny Workflow in Cardiovascular Effects Evaluations Thursday 10:05-11:30 |
| III-59 Tim Preijers In silico evaluation of limited blood sampling strategies for individualized recombinant factor IX prophylaxis in hemophilia B patients Thursday 10:05-11:30 |
| III-61 Angelica Quartino Comparisons of Multiple Exposure-Response Methodologies in Oncology Thursday 10:05-11:30 |
| III-64 Christian Hove Claussen Automated modeling workflow with LaTeX: using the new Pfizer Report Tool Thursday 10:05-11:30 |
| III-76 Richard Pugh Data Science & Big Data: An Opportunity or a threat for Pharmacometrics? Thursday 10:05-11:30 |
| IV-01 Nikita Sakhanenko New information-theory-based methods in the analysis of childhood development data Thursday 14:40-16:00 |
| IV-10 Mike K Smith Model Description Language (MDL) - a standard for model communication and interoperability Thursday 14:40-16:00 |
| IV-21 Maciej Swat PharmML & SO - standards for encoding models and results in PMX and QSP Thursday 14:40-16:00 |
| IV-39 Moreno Ursino Evaluating phase I studies in small populations when incorporating pharmacokinetic information Thursday 14:40-16:00 |
| IV-45 Tamara van Donge Evaluating biosimilarity of monoclonal antibodies: comparison of population approach nonlinear mixed effects models to standard non-compartmental analysis Thursday 14:40-16:00 |
| IV-66 Xia Li Population pharmacokinetics of multiple oral doses of alcohol in humans using blood and breath measures Thursday 14:40-16:00 |
